Pharma Company Funding Anti-Pot Fight Worried About Losing Business, Filings Show

Posted on September 13, 2016September 30, 2016 by WOCredentials

“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”

Related Posts

Cannabinoids as novel anti-inflammatory drugs (2009)

WOCredentials
June 16, 2016
0

“It is becoming increasingly clear that cannabinoid receptors and their endogenous ligands play a crucial role in the regulation of the immune system. Exogenous cannabinoids have been shown to suppress […]

Cannabinoid improves survival rates of mice with pancreatic cancer

WOCredentials
July 31, 2018
0

“Mice with pancreatic cancer that were treated with a naturally occurring constituent of medicinal cannabis alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone, a new […]

Cannabis

A pharma company that spent $500,000 trying to keep pot illegal just got DEA approval for synthetic marijuana

WOCredentials
March 29, 2017
0

“Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement […]